Ubiquitin News and Research

RSS
Ubiquitin is a small regulatory protein that has been found in almost all cells (''ubiquitously'') with nuclei (eukaryotes). It directs proteins to recycling and other functions.
Researchers discover key immune mechanism that helps control inflammatory response to infection

Researchers discover key immune mechanism that helps control inflammatory response to infection

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

IU study sheds new light on the development and treatment of rare form of muscular dystrophy

IU study sheds new light on the development and treatment of rare form of muscular dystrophy

FDA-approved drug keeps light-sensitive photoreceptors alive in lab models of LCA 10

FDA-approved drug keeps light-sensitive photoreceptors alive in lab models of LCA 10

Study shows SARS-CoV-2 causes DNA damage and elicits an altered DNA damage response

Study shows SARS-CoV-2 causes DNA damage and elicits an altered DNA damage response

PARK2 duplication or microdeletion and neurological diseases

PARK2 duplication or microdeletion and neurological diseases

Study characterizes N-terminal domain structure of a ubiquitin ligase TRAF6

Study characterizes N-terminal domain structure of a ubiquitin ligase TRAF6

Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

UIC scientists find new way to better target cellular proteins

UIC scientists find new way to better target cellular proteins

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

Molecular switch regulates autophagy in plants

Molecular switch regulates autophagy in plants

Study provides an estimate of people in the United States with VEXAS syndrome

Study provides an estimate of people in the United States with VEXAS syndrome

Study identifies new tau regulators as viable therapeutic targets for Alzheimer's and other tauopathies

Study identifies new tau regulators as viable therapeutic targets for Alzheimer's and other tauopathies

The loss of epigenetic information accelerates the aging process

The loss of epigenetic information accelerates the aging process

Ubiquigent appoints Dr Xavier Jacq to Scientific Advisory Board

Ubiquigent appoints Dr Xavier Jacq to Scientific Advisory Board

Circulating microparticle proteins predict placenta accreta spectrum before delivery

Circulating microparticle proteins predict placenta accreta spectrum before delivery

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

Research reveals a novel viral strategy in modulating stress granule formation to promote virus infection

Research reveals a novel viral strategy in modulating stress granule formation to promote virus infection

The effect of ubiquitination on SARS-CoV-2 infection and patient prognosis

The effect of ubiquitination on SARS-CoV-2 infection and patient prognosis

Unique peptides with anti-cancer potential discovered

Unique peptides with anti-cancer potential discovered

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.